Article ID Journal Published Year Pages File Type
3284342 Clinical Gastroenterology and Hepatology 2009 8 Pages PDF
Abstract
Community gastroenterologists and UC experts vary dramatically in their approach to many areas of uncertainty in UC. The only area of consensus between groups is the use of infliximab over cyclosporine in steroid-refractory UC, itself a controversial decision. These data suggest that current practice patterns are highly disparate and focus attention on specific areas of disconnect that should be further investigated.
Related Topics
Health Sciences Medicine and Dentistry Gastroenterology
Authors
, , , , , , , ,